The purpose of this clinical trial is learn whether a behavioral (non-medication) treatment can reduce nightmares in adults with Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD). People with RBD will be enrolled in the study along with their family members (a partner or other family member residing in the same home). All participants will receive the treatment via videoconference and will complete 2 assessments. Participants with RBD will attend 7 sessions, and their family members will attend 2 of those sessions with them.
Diagnosis of isolated RBD or RBD secondary to neurodegenerative disease
Age 18 or older
Speak, read, and write English
Live in the United States
Possible dementia
Narcolepsy
Posttraumatic stress disorder
Previous behavioral treatment for nightmares
Parallel
Cognitive Behavioral Therapy for Nightmares
BehavioralThe intervention will consist of 7 therapy sessions (once per week for 7 weeks) which will be delivered via videoconference. Family members will attend 2 of the 7 treatment sessions. During the sessions, participants will learn techniques for managing and changing nightmares.
Disturbing Dream and Nightmare Severity Index (DDNSI)
The DDNSI is a questionnaire which measures the severity of nightmares.
Nightmare frequency (sleep diary)
The number of nightmares experienced each day will be collected on daily sleep diaries completed during each assessment period.
Click on the lead sponsor to view all of their trials.
